Stay updated on Cusatuzumab Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.

Latest updates to the Cusatuzumab Combo in AML: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.3 is added and the HHS Vulnerability Disclosure link is removed. Revision: v3.3.2 is removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRecord History now includes a new revision entry for v3.3.2. The previous revision v3.3.1 has been removed.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 with no changes to study data, descriptions, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding/operating status notice banner was removed from the page, and this change does not affect the study record data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedAdditional history versions were added to the Record History page, expanding past submissions and updates including study status and contact/location details.SummaryDifference0.1%

- Check88 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference9%

Stay in the know with updates to Cusatuzumab Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.